Prevention of atherothrombotic events: can we do better?
With an unrestricted educational grant from MSD
Chairperson: D. Atar
Co-chairperson: J.P. Collet
- To discuss that patients with a history of myocardial infarction and/or peripheral artery disease are at high short and long-term risk for atherothrombotic events despite standard therapy
- To educate on the multiple pathways involved in the activation of platelets
- To appreciate the PAR-1 pathway as a key platelet activation pathway that is critical for thrombosis